Cardiac Stress and Inflammatory Markers as Predictors of Heart Failure in Patients With Type 2 Diabetes: The ADVANCE Trial

CONCLUSIONS
Only NT-proBNP strongly and consistently improved the prediction of heart failure in patients with type 2 diabetes beyond a wide range of clinical risk factors and biomarkers.

Source: Diabetes Care - August 22, 2017 Category: Endocrinology Authors: Ohkuma, T.; Jun, M.; Woodward, M.; Zoungas, S.; Cooper, M. E.; Grobbee, D. E.; Hamet, P.; Mancia, G.; Williams, B.; Welsh, P.; Sattar, N.; Shaw, J. E.; Rahimi, K.; Chalmers, J.; on behalf of the ADVANCE Collaborative Group Tags: Epidemiology/Health Services Research Source Type: research